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Abstract 
Introduction: Asthma is a common chronic inflammatory disease of the airways characterized by reversible 
airflow obstruction, and bronchospasm. The first line of treatment in the management of acute asthma is inhaled 
beta 2 agonists (salbutamol). This study is designed to determine the effectiveness of intravenous dexamethasone 
compared to oral prednisolone in asthmatic children in preventing exacerbation and relapse. It may be more 
helpful in improving the quality of life of asthmatic children being a better convenient treatment modality. 
Aim: To compare the frequency of relapse of asthma with dexamethasone and prednisolone in the treatment of 
asthma exacerbations in children. 
Subject and Methods:  This is a randomized controlled study that was conducted at the ICU of the Paediatric 
Department, Holy Family Hospital from 16th March 2016 to 15th September 2016. 468 patients with asthma 
exacerbation were selected in this study. Patients were randomly allocated into two groups. A total of 234 patients 
in group A were treated with single IV dose Dexamethasone and 234 in group B were treated with oral 
prednisolone. Baseline characteristics of children were recorded in the structured proforma along with signs and 
symptoms assessed through history, physical examination and PRAM (Paediatric Respiratory Assessment 
Measurement) Scoring. After treatment and assessment, the patients were discharged on day 5 and they were 
called back by the end of 2 weeks for the final follow up visit. In case of any relapse, they were clearly instructed 
to immediately return to the hospital which was recorded. 
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Results: The average age of the children 3.31±0.97 years. There were 173(37%) females and 295(63%) males. The 
rate of relapse was significantly low in group A as compared to group B (9.8% vs. 17.9% p=0.011).  
Conclusion: it is concluded that dexamethasone is an effective alternative to prednisone in the treatment of 
moderate acute asthma exacerbations in children, with the added benefits of improved compliance and cost.  
Keywords: Asthma, Prednisolone, Relapse of dexamethasone. 
 
 
 
Introduction 
 
Asthma is a significant health problem worldwide, 
and it is one of the most common chronic diseases of 
childhood in many countries.1 The prevalence in 
different countries ranges from 1 to 18 percent. In the 
United States, for example, asthma affects more than, 
seven million children.2 
Asthma is a common chronic inflammatory disease of 
the airways characterized by reversible airflow 
obstruction, and bronchospasm. Symptoms include 
wheezing, coughing, chest tightness, and shortness of 
breath. The diagnosis is clinical, made by physicians.3 
Prevalence of asthma is increasing all over the world 
and is greater in children than adults.4 
Prevalence rates for current asthma in children under 
age 18 years increased in the United States from 2001 
to 2009 (8.7 to 9.7 percent) and then plateaued.5 
Asthma is a major cause of morbidity and school 
absences3. Asthma exacerbations are the leading cause 
of emergency visits and hospitalization in children.6 
A short course of systemic corticosteroids is an 
effective part of the management of acute asthma 
exacerbation. By reducing airway inflammation, 
steroids help manage acute symptoms and reduce 
bronchodilator use and relapse rates.7 
The British Thoracic Society (BTS) Guidelines on the 
Management of Asthma (May 2008, revised January 
2012) recommend commencing oral prednisolone early 
for children presenting with exacerbations of asthma 
and if discharged, continuing treatment, for up to 
three days.8 
The first line of treatment in the management of acute 
asthma is inhaled beta 2 agonists (salbutamol) and is 
now the mainstay of treatment.  
This study is designed to determine the effectiveness 
of intravenous dexamethasone compared to oral 
prednisolone in asthmatic children in preventing 
exacerbation and relapse. It may more helpful in 
improving the quality of life of asthmatic children 
being a better convenient treatment modality. 
 
 
Material and Methods 
The study was conducted in admitted patients in the 
ICU of Paediatrics Department, Holy Family Hospital 
Rawalpindi from 16-03-2016 to 15-09-2016 (6-months). 
The study design was a randomized control trial. 
468 patients with asthma exacerbation were selected in 
this study. Patients were randomly allocated into two 
groups. A total of 234 patients in group A were treated 
with single intravenous dose Dexamethasone and 234 
in group B was treated with oral prednisolone. 
Baseline characteristics of children were recorded in 
the structured proforma along with the signs and 
symptoms assessed through history, physical 
examination and PRAM Scoring. After treatment and 
assessment, the patients were discharged on day 5 and 
they were called back by the end of 2 weeks for the 
final follow up visit. In case of any relapse, they were 
clearly instructed to immediately return to the hospital 
that was recorded. Inclusion criteria were as follows 
⦁ Children 2—5 years of age 
⦁ Both sexes  
⦁ Children presenting with moderate asthma 
exacerbation (PRAM Score 4—7) were included. 
Patients who were fulfilling the criteria, admitted in 
Pediatric Ward Holy Family Hospital were divided 
randomly into two groups A and B by lottery method. 
PRAM score was assessed on day 0 before treatment, 
as baseline PRAM that was moderate for all children 
as specified in inclusion criteria. Group A was given 
single IV dose Dexamethasone at a dose of 0.6 mg/kg 
(Max 16mg) on day 0. Group B was given oral 
Prednisone at a dose of 2 mg/kg/day (Max 60mg) 
single dose for five days (day 0—5). Daily PRAM 
Scoring was done in both study groups from day1—
day 5 to assess the severity of exacerbation and 
occurrence of an episode of vomiting or discomfort. 
After treatment and assessment, the patients were 
discharged on day 5 and they were called back by the 
end of 2 weeks for the final follow up visit.  
Data was entered and analyzed in SPSS version 19.0. A 
chi-square test was applied to compare the relapse rate 
within 2 weeks between groups. P-value ≤ 0.05 was 
taken as statistically significant. 
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Result 
 
Four hundred and sixty-eight patients with asthma 
exacerbation were selected in this study. Patients were 
randomly allocated into two groups. A total of 234 
patients in group A were treated with single IV dose 
Dexamethasone and 234 in group B were treated with 
oral prednisolone. The age distribution of the patients 
is shown in Figure 1. The average age of the children is 
3.31±0.97 years. The mean age with respect to groups 
is displayed in Table 1. There were 173(37%) females 
and 295(63%) male as shown in Figure 2.  
The rate of relapse was significantly low in group A as 
compared to group B (9.8% vs. 17.9% p=0.011) as 
presented in Table 2. Stratification analysis, with 
respect to age groups, is showing that the rate of 
relapse was also low in group A than group B as 
shown in table 3 while the rate of relapse was not 
statistically significant between groups for 4 to 5 years 
of age group children (Table 4). Gender-wise 
stratification was performed and observed that in male 
cases there was no significant change while in female 
cases; the rate of relapse was also low in group A than 
group B as shown in Tables 5 and 6. 
 
 
Figure 1: Age Distribution of the Patients 
 
Figure 2: Gender Distribution of the Patients 
 
Table 1: Descriptive Statistics of Age For Both 
Groups 
Descriptive Statistics Age (Years) 
Group A Group B 
Mean 3.32 3.29 
Std. Deviation 0.99 0.95 
95% 
Confidence 
Interval for 
Mean 
Lower 
Bound 
3.20 3.17 
Upper 
Bound 
3.45 3.41 
Median 3.22 3.33 
Interquartile Range 1 1 
Minimum 2 2 
Maximum 6 5 
 
Table 2: Comparison of the frequency of relapse of 
dexamethasone prednisolone in the treatment of 
asthma exacerbation in children 
Relapse Group A 
n=234 
Group B 
n=234 
Chi-
Square 
P-Value 
Yes 23(9.8%) 42(17.9%) 6.45 0.011 
No 211(90.2%) 192(82.1%) 
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Table 3: Comparison of the frequency of relapse 
between treatments of asthma exacerbation in 
children aged 2 to 3 years 
Relapse Group A 
n=150 
Group B 
n=143 
Chi-
Square 
P-
Value 
Yes 15(10%) 28(19.6%) 5.36 0.021 
No 135(90%) 115(80.4%) 
 
Table 4: Comparison of the frequency of relapse 
between treatments of asthma exacerbation in 
children for 4 to 5 years of age 
Relapse Group A 
n=84 
Group B 
n=91 
Chi-
Square 
P-
Value 
Yes 8(9.5%) 14(15.4%) 1.36 0.24 
No 76(90.5%) 77(84.6%) 
 
Table 5: Comparison of the frequency of relapse 
between treatments of asthma exacerbation in male 
children 
Relapse Group A 
n=146 
Group B 
n=149 
Chi-
Square 
P-
Value 
Yes 15(10.3%) 22(14.8%) 1.35 0.29 
No 131(89.7%) 127(85.2%) 
 
Table 6: Comparison of the frequency of relapse 
between treatments of asthma exacerbation in 
female children 
Relapse Group A 
n=88 
Group B 
n=85 
Chi-
Square 
P-
Value 
Yes 8(9.1%) 20(23.5%) 6.64 0.010 
No 80(90.9%) 65(76.5%) 
 
Discussion 
 
Asthma is among the most common paediatric chronic 
diseases and a frequent reason for emergency 
department (ED) visits and hospitalization.9 There are 
various triggers of acute exacerbation of asthma. 
Bronchospasm and airway inflammation with edema 
and mucus production are key physiologic factors 
leading to clinical symptoms. One of the important 
mainstays in therapy for moderate to severe asthma 
exacerbations is a short course of systemic 
corticosteroids.10 
Four hundred and sixty-eight patients with an asthma 
exacerbation aged from 2-5 years were selected in our 
study. The average age of the children was 3.31±0.97 
years. There were 37% females and 63% males which 
demonstrate a higher prevalence of asthma in males. 
Osman et al.11 showed that the prevalence of asthma 
per 100 populations was 9.8 for males and 7.3 for 
females at the age of 5 years. In general, the lifetime 
likelihood of developing asthma is about 10.5% greater 
in women than men.12 When examined at specific time 
period, asthma is more common and more severe in 
pre-pubertal boys, with boys less than 18 years of age 
having a 54% higher rate of asthma than girls of the 
same age.12 
In our study, the rate of relapse was significantly low 
in group A (single iv dose Dexamethasone) as 
compared to group B (oral prednisolone). In 2001, 
Qureshi et al.13 compared 2 days of dexamethasone 
(0.6 mg/kg daily; maximum 16 mg/d) to 5 days of 
prednisolone (1 mg/kg daily; maximum 60 mg/d). 
Dexamethasone had similar efficacy as measured by 
relapse rates, hospitalization rates, and the persistence 
of symptoms at 10 days. Altamimi et al.14 reported that 
a single dose of oral dexamethasone was no worse 
than a 5-day course of prednisone in mild or moderate 
asthma exacerbations. Gordon S et al.15 showed that a 
single intramuscular dose of dexamethasone did not 
result in meaningful differences in mean total asthma 
scores at 4-day follow-up for children discharged from 
the ED with moderate asthma exacerbation. Reviews 
of Cross et al.16 and Redman and Powell 17 concluded 
that, according to the literature, dexamethasone and 
prednisone are of equal efficacy in treating pediatric 
asthma exacerbations.16,17 
In February 2014, a recent meta-analysis by Keeney et 
al. found the difference in relative risk of relapse 
between two groups (DEXA 6.6% vs prednisolone 
3.6%) and suggested the use of single-dose 
dexamethasone as a viable alternative to a 5-day 
regimen of prednisolone.18 Recent studies have shown 
that a single dose of dexamethasone is as effective, if 
not more, as multi-dose prednisone with the added 
advantage of improved compliance.16 
Kandasamy P. et al in their study conducted in 2018 
concluded that a single dose of oral dexamethasone is 
as effective as 3 daily doses of prednisolone in children 
with moderate exacerbation of asthma.19 Cronin JJ et al 
revealed that in children with acute exacerbations of 
asthma, a single dose of oral dexamethasone is as 
effective as to a three-day course of oral 
prednisolone.20 Paniagua N et al conducted a study in 
2018 and they were of the opinion that two doses of 
dexamethasone may be an effective alternative to a 5-
day course of prednisolone for asthma exacerbations.21 
Grant E et al in their study conducted in 2014 
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emphasized that emergency physicians should 
consider a two-day dexamethasone regimen over 5-
day prednisolone regimens for the treatment of acute 
asthma exacerbations.22 This is in accordance with our 
study results. 
 
Conclusion 
  
The current study of determining the effectiveness of 
dexamethasone compared to prednisolone in 
asthmatic children found that the rate of relapse was 
significantly low in group A (single IV dose of 
dexamethasone) as compared to group B (oral 
prednisolone). It is suggested that dexamethasone can 
be used as an effective alternative to prednisolone in 
the treatment of moderate acute asthma exacerbation 
in children with the added benefits of improved 
compliance and cost. 
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